LabCompass

Mahmoud Abdel‐Rasoul

Medicine · The Ohio State University

Mid career · publishing since 2007

Publications

264

Citations

3,791

Est. group size

~6

Recurring co-author estimate

Active years

20

Publishing since 2007

Research summary
AI-generated

This researcher contributes to a wide range of clinical studies spanning pediatric gastroenterology, oncology, pain management, and pharmacy practice, often as part of larger multi-author clinical research teams. Much of the work involves analyzing patient outcomes, treatment switching (such as between biosimilar and originator drugs), medication costs, and pain management strategies after surgery. This research relies heavily on clinical and administrative data (e.g., insurance claims, patient records) to compare treatments and outcomes rather than laboratory-based experiments.

Biosimilar drug switching and outcomesPediatric inflammatory bowel diseasePerioperative pain and opioid managementClinical pharmacy practiceOncology clinical trials

Publication output grew substantially from 2017 to a peak around 2023, and has remained fairly steady at a high level (about 20+ papers per year) through 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 20.4/year recently
2017: 14 publications172018: 9 publications182019: 18 publications192020: 29 publications202021: 21 publications212022: 23 publications222023: 30 publications30232024: 23 publications242025: 22 publications252026: 4 publications26
Recent publications
Publishes in
  • Gastroenterology×13
  • The Annals of Thoracic Surgery×10
  • Inflammatory Bowel Diseases×7
  • Journal of the American College of Cardiology×6
  • Journal of Thoracic and Cardiovascular Surgery×5
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile